Email Updates

You are here

6 DECEMBER 2019 VOLUME 20 ISSUE 47

Media Coverage

  • Currently, all recommended initial HIV treatment/prevention regimens include daily oral administration. Novel formulations are necessary to provide options for patients who have difficulty swallowing, a history of medication nonadherence, or concerns about HIV disclosure or even those learning to cope with their HIV diagnosis.

    December 6, 2019
    Contagion Live
  • In an unusual move, an advocacy group asked federal authorities to reject a request by Gilead Sciences (GILD) for a three-year patent extension on an HIV drug because the company allegedly lied about important information in its application.

    December 6, 2019
    STAT News
  • A lot has changed since the first cases of AIDS were reported in 1981. Globally, AIDS-related deaths have dropped by more than 55 percent since 2004, the deadliest year on record. But, the road to effective treatment for HIV, the virus that causes AIDS, was long.

    December 4, 2019
    NPR
  • As we approach 2020 — a pivotal year on many levels — we have more options and a clearer picture than ever of what must be done to end the HIV epidemic globally.

    December 3, 2019
    Devex
  • Buried within a 2009 New England Journal of Medicine article on an HIV vaccine regimen was a sentence that would change the face of HIV vaccine research for the next decade: "the modified intention-to-treat analysis showed a significant, though modest reduction in the rate of HIV-1 infection as compared with placebo."

    December 3, 2019
    MedPage Today
  • With donated drugs and services provided by major pharmacy chains, 200,000 uninsured Americans will gain access to HIV-preventive medicines at no cost, the Trump administration announced on Tuesday.

    December 3, 2019
    New York Times
  • Only 40 percent of US adults have ever been tested for HIV, and fewer than a fifth of the people at high risk for developing the infection are receiving the medication that prevents it, the government reported Tuesday.

    December 3, 2019
    General
    Washington Post
  • One big task for Gilead Sciences’ HIV franchise in the coming year is to save some $2.5 billion in annual sales by switching as many PrEP patients as possible from Truvada to newly approved Descovy before generics hit.

    December 3, 2019
    Fierce Pharma
  • When Stellenbosch University offered her a job, Vuyiseka Dubula-Majola was circumspect. Why would she take up appointment at a white male-dominated institution, shackled by slow transformation in an elitist town?

    December 2, 2019
    General
    Daily Maverick
  • When PrEP—or pre-exposure prophylaxis, a daily pill that protects against HIV—came on the US market in 2012, it captured the attention primarily of men who have sex with men. According to the Food and Drug Administration, the first PrEP pill, Truvada, provides over 90 percent protection from sexually acquiring HIV when taken daily. Logically, this is a boon to women who may not be able to insist on condoms or prefer not to use them. So why did the FDA recently approve a new PrEP pill without approving it for cisgender women’s use?

    December 2, 2019
    Rewire.News
  • You may have heard about HIV pre-exposure prophylaxis, commonly referred to as PrEP, from media reports or your local clinic. You may have been curious to find out more, but then words like ‘high-risk group’, ‘sex workers’ and ‘men who have sex with men’ were used and you decided it wasn’t for you.

    December 2, 2019
    Daily Maverick
  • While the global HIV/AIDS community has made great strides toward the Joint United Nations Programme on HIV/AIDS’ 90-90-90 goals and the US President’s Emergency Plan for AIDS Relief’s epidemic control goals, there is still a long journey ahead to end the AIDS epidemic by 2030.

    December 2, 2019
    Devex
  • while robust municipal health campaigns are creating downward HIV trends in some of America’s largest cities, in much of rural America, an opposite trend is emerging. There have of course always been cases of HIV in sparsely populated parts of the country, but in these places far from cities, the conditions that lead to HIV transmission are now intensifying — and rural America is not ready for the coming crisis.

    December 1, 2019
    General
    New York Times
  • Diagnosis of HIV in Ireland is increasing despite new initiatives to tackle the issue. There have been 476 new diagnoses of HIV this year, compared to 447 in the same time period last year. Ireland ranks almost double the European average, with higher numbers than during the Aids epidemic in the 1980s and 1990s.

    December 1, 2019
    General
    Irish Times
  • The global fight against the human immunodeficiency virus is poised to make important advances thanks to three experimental HIV vaccines that are entering the final stages of testing at sites across the globe.

    December 1, 2019
    NBC News
  • As people around the world commemorate World AIDS Day, in many countries, the disease is still cutting lives short at an alarming rate. Of the 770,000 AIDS-related deaths in 2018, almost two-thirds occurred in Africa and the Middle East where infected people have little access to treatment.

    December 1, 2019
    CNN
  • The future of global HIV response must be very different from today’s efforts. It must be youth focused and youth led. Otherwise, many of our successes against HIV may be endangered by the rapid growth of vulnerable youth populations in the highest burden countries. Nearly two-thirds of Africa’s population is under 25.

    December 1, 2019
    General
    Global Health Now
  • The theme of this year's World AIDS Day is "Communities make the difference". It is a great chance to acknowledge the critical contribution civil society and advocacy groups have made in the global fight against AIDS. Without them, 24 million people would not be on lifesaving anti-retroviral treatment today.

    November 30, 2019
    General
    Forbes
  • A long civil war ended in 2002 but disasters, poverty and food insecurity have allowed Aids-related deaths to rise by more than 33 percent in the past decade. The number of new HIV infections is also on the rise and too many pregnant women are not getting access to medicines to protect their babies.

    November 30, 2019
    General
    The Guardian
  • About 80,000 babies and toddlers die of AIDS each year, mostly in Africa, in part because their medicines come in hard pills or bitter syrups that are very difficult for small children to swallow or keep down.

    November 29, 2019
    New York Times
  • AIDS has no cure. HIV is still here. But some people are forgetting that. Those are some of the bold messages Uganda’s leader is emphasizing as health officials try to stem stubbornly high infection rates among young people in this East African country that years ago won praise as a global leader in fighting the epidemic.

    November 29, 2019
    Associated Press
  • By the time the young man arrived at Dr. Jonathan Colasanti’s office in downtown Atlanta, he had already visited numerous emergency rooms across the city, complaining of pain and abscesses around his tailbone. Despite undergoing copious tests, no one could determine the cause. It was only when he went to a leading medical center where Colasanti works that someone thought to test him for HIV. The results came back positive.

    November 29, 2019
    General
    TIME
  • Much of the progress in fighting HIV/AIDS is thanks to treatments such as antiretroviral (ARV) drugs. Alongside those, however, are other innovations that have provided models for broader moves towards universal health coverage.

    November 28, 2019
    General
    Financial Times
  • A newborn immune system responds to HIV infection less effectively than a more mature one, so an HIV-positive baby should be started on antiretroviral therapy as soon after birth as possible, new research suggests.

    November 27, 2019
    Scientific American

Published Research

Announcements